Gynecological

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(Merck) MK-7902-001 / E7080-G000-313 / LEAP-001A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial CarcinomaHirte, Dr HalOpen to recruitmentNCT03884101
(Roche) WO42017 / SKYSCRAPER 04A PHASE II, SAFETY, AND EFFICACY STUDY OF TIRAGOLUMAB PLUS ATEZOLIZUMAB AND ATEZOLIZUMAB MONOTHERAPY IN PATIENTS WITH METASTATIC AND/OR RECURRENT
PD-L1−POSITIVE CERVICAL CANCER
Hirte, Dr HalOpen to recruitmentNCT04300647
(Tesaro) 3000-03-005 / ENGOT-OV44 / FIRSTA Patient Centric Randomized Phase 3 Comparison of Standard of Care Platinum Based Therapy to the Same Plus TSR-042 As First Line Treatment of Patients with Stage III or IV Non-Mucinous Ovarian Cancer.Hirte, Dr HalOpen to recruitmentNCT03602859
(UHN) BioDIVABiomarker Discovery Project in High Grade Serous Ovarian CancerReade, Dr ClareRecruitment on hold - COVID-19NCT03419689
Download PDF